Cargando…
Genetic and Molecular Mechanisms in Brugada Syndrome
Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardiac death in young adults. Despite recent advances, it remains a complex condition, encompassing mechanisms, genetics, dia...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340412/ https://www.ncbi.nlm.nih.gov/pubmed/37443825 http://dx.doi.org/10.3390/cells12131791 |
_version_ | 1785072073268264960 |
---|---|
author | Moras, Errol Gandhi, Kruti Narasimhan, Bharat Brugada, Ramon Brugada, Josep Brugada, Pedro Krittanawong, Chayakrit |
author_facet | Moras, Errol Gandhi, Kruti Narasimhan, Bharat Brugada, Ramon Brugada, Josep Brugada, Pedro Krittanawong, Chayakrit |
author_sort | Moras, Errol |
collection | PubMed |
description | Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardiac death in young adults. Despite recent advances, it remains a complex condition, encompassing mechanisms, genetics, diagnosis, arrhythmia risk stratification, and management. The underlying electrophysiological mechanism of Brugada syndrome requires further investigation, with current theories focusing on abnormalities in repolarization, depolarization, and current-load match. The genetic basis of the syndrome is strong, with mutations found in genes encoding subunits of cardiac sodium, potassium, and calcium channels, as well as genes involved in channel trafficking and regulation. While the initial discovery of mutations in the SCN5A gene provided valuable insights, Brugada syndrome is now recognized as a multifactorial disease influenced by several loci and environmental factors, challenging the traditional autosomal dominant inheritance model. This comprehensive review aims to provide a current understanding of Brugada syndrome, focusing on its pathophysiology, genetic mechanisms, and novel models of risk stratification. Advancements in these areas hold the potential to facilitate earlier diagnosis, improve risk assessments, and enable more targeted therapeutic interventions. |
format | Online Article Text |
id | pubmed-10340412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103404122023-07-14 Genetic and Molecular Mechanisms in Brugada Syndrome Moras, Errol Gandhi, Kruti Narasimhan, Bharat Brugada, Ramon Brugada, Josep Brugada, Pedro Krittanawong, Chayakrit Cells Review Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardiac death in young adults. Despite recent advances, it remains a complex condition, encompassing mechanisms, genetics, diagnosis, arrhythmia risk stratification, and management. The underlying electrophysiological mechanism of Brugada syndrome requires further investigation, with current theories focusing on abnormalities in repolarization, depolarization, and current-load match. The genetic basis of the syndrome is strong, with mutations found in genes encoding subunits of cardiac sodium, potassium, and calcium channels, as well as genes involved in channel trafficking and regulation. While the initial discovery of mutations in the SCN5A gene provided valuable insights, Brugada syndrome is now recognized as a multifactorial disease influenced by several loci and environmental factors, challenging the traditional autosomal dominant inheritance model. This comprehensive review aims to provide a current understanding of Brugada syndrome, focusing on its pathophysiology, genetic mechanisms, and novel models of risk stratification. Advancements in these areas hold the potential to facilitate earlier diagnosis, improve risk assessments, and enable more targeted therapeutic interventions. MDPI 2023-07-05 /pmc/articles/PMC10340412/ /pubmed/37443825 http://dx.doi.org/10.3390/cells12131791 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Moras, Errol Gandhi, Kruti Narasimhan, Bharat Brugada, Ramon Brugada, Josep Brugada, Pedro Krittanawong, Chayakrit Genetic and Molecular Mechanisms in Brugada Syndrome |
title | Genetic and Molecular Mechanisms in Brugada Syndrome |
title_full | Genetic and Molecular Mechanisms in Brugada Syndrome |
title_fullStr | Genetic and Molecular Mechanisms in Brugada Syndrome |
title_full_unstemmed | Genetic and Molecular Mechanisms in Brugada Syndrome |
title_short | Genetic and Molecular Mechanisms in Brugada Syndrome |
title_sort | genetic and molecular mechanisms in brugada syndrome |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340412/ https://www.ncbi.nlm.nih.gov/pubmed/37443825 http://dx.doi.org/10.3390/cells12131791 |
work_keys_str_mv | AT moraserrol geneticandmolecularmechanismsinbrugadasyndrome AT gandhikruti geneticandmolecularmechanismsinbrugadasyndrome AT narasimhanbharat geneticandmolecularmechanismsinbrugadasyndrome AT brugadaramon geneticandmolecularmechanismsinbrugadasyndrome AT brugadajosep geneticandmolecularmechanismsinbrugadasyndrome AT brugadapedro geneticandmolecularmechanismsinbrugadasyndrome AT krittanawongchayakrit geneticandmolecularmechanismsinbrugadasyndrome |